Throughout Friday’s buying and selling session, the shares of an organization engaged within the enterprise of buying and selling and dealing in agriculture commodities hit a recent 52-week excessive on BSE, after the corporate introduced securing a purchase order order value almost Rs. 12 crores.
Worth Motion
With a market capitalisation of Rs. 13.8 crores, the shares of Eureka Industries Restricted hit a report excessive at Rs. 16.88, as towards its earlier closing worth of Rs. 16.08. The inventory has delivered multibagger returns of almost 310 p.c over a one-year interval, whereas round 16 p.c of optimistic returns within the final one month.
What’s the Information
Based on the newest regulatory filings with BSE, Eureka Industries Restricted obtained a purchase order order valued at Rs. 12.1 crores from Grainspan Vitamins Non-public Restricted. The order includes the provision of 5000 MT of Maize (Makka), with the order to be executed by thirty first Could 2025.
Additionally learn: Pharma inventory to purchase now for an upside potential of greater than 25%; Do you personal it?
Financials
Eureka Industries skilled important progress in its income from operations, exhibiting a year-on-year rise of 442 p.c from Rs. 6.63 crores in Q3 FY24 to Rs. 35.94 crores in Q3 FY25. Equally, the corporate turned its web lack of Rs. 2.02 crores to a revenue of Rs. 0.8 crores, throughout the identical interval.
Concerning the Firm
Eureka Industries Restricted is engaged within the enterprise of buying and selling agriculture merchandise and associated supplies. The corporate’s buying and selling portfolio encompasses wheat, rice, paddy, maize, and pulses.
Moreover, Eureka plans to steadily develop its operations to incorporate the cultivation of a variety of agricultural merchandise, comparable to fruits, greens, seeds, cereals, pulses, grains, rice, lentils, money crops, corn, hay, and straw, utilizing sustainable and natural farming strategies
Written by Shivani Singh
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of economic losses. Traders should subsequently train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer are usually not responsible for any losses brought about because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
